Marmoset CYP1A2: primary structure and constitutive expression in livers

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Cytochrome P450 enzymes play crucial roles in xenobiotic metabolism.
• CYP1A2 is a significant isoform involved in the metabolism of various endogenous and exogenous compounds.
• Understanding species-specific differences in CYP1A2 expression and activity is vital for drug development and risk assessment.

Purpose of the Study:

• To isolate and characterize marmoset CYP1A2.
• To investigate the tissue-specific expression and inducibility of marmoset CYP1A2 mRNA.
• To assess the metabolic activity of marmoset CYP1A2 towards known substrates and mutagens.

Main Methods:

• Complementary DNA (cDNA) isolation via library screening and reverse-transcriptase polymerase chain reaction (RT-PCR).
• S1 nuclease protection assay for mRNA expression analysis.
• Umu mutagenicity test and ethoxyresorufin O-deethylase activity assay for functional characterization.

Main Results:

• Marmoset CYP1A2 shares high amino acid sequence identity with human and cynomolgus monkey orthologs.
• CYP1A2 mRNA is constitutively expressed in marmoset liver and inducible by 3-methylcholanthrene and polychlorinated biphenyls.
• Recombinant marmoset CYP1A2 efficiently activates heterocyclic amines (IQ, MeIQx, PhIP) and exhibits ethoxyresorufin O-deethylase activity.

Conclusions:

• Marmosets constitutively express CYP1A2 in the liver, analogous to humans.
• Marmoset CYP1A2 is a functional enzyme capable of metabolizing various substrates, including potent mutagens.
• This study provides valuable insights into marmoset drug metabolism and its relevance as a preclinical model.